Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Last updated: April 21, 2025
Sponsor: Charite University, Berlin, Germany
Overall Status: Completed

Phase

N/A

Condition

Sarcopenia

Polymyositis (Inflammatory Muscle Disease)

Treatment

N/A

Clinical Study ID

NCT05591950
TAVIMS
  • Ages > 18
  • All Genders

Study Summary

Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS).

The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Critically ill adults (age: ≥ 18 years)

  • Expected length of stay in ICU > 24h

  • Ventilation support

Exclusion

Exclusion Criteria:

  • Patients transferred from other ICUs

  • Patients with pre-existing functional limitations

  • Patients with functional limitations due to the admission diagnosis (e.g. stroke.with hemiparesis)

Study Design

Total Participants: 100
Study Start date:
January 24, 2023
Estimated Completion Date:
February 20, 2025

Connect with a study center

  • Charité - Univiversitätsmedizin Berlin

    Berlin, 10117
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.